OpenVSafe by OpenVAERS
Search V-safe

PML-31967-09020

3 vaccinations 1 coded response 8 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
12-15
ZIP prefix
981 / WA
Registered
2022-01-28
Relationship
Child or adolescent in my care
Guardian
CWK-23439-94318
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-08
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-11
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-28
    Registered in v-safe
  5. 2022-01-28
    Survey response — day 14, dose 3, dependent
    MedDRA: Myalgia, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fever, myalgia less than a day after the vaccine
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-02-01
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  7. 2022-02-08
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  8. 2022-02-15
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  9. 2022-02-22
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  10. 2022-04-12
  11. 2022-07-12
  12. 2023-01-11

Vaccinations

DoseDateManufacturerCo-administered
12021-05-13Pfizer-BioNTech No
22021-06-08Pfizer-BioNTech No
32022-01-11Pfizer-BioNTech No

Free text

Release 11 — day 14, dose 3, dependent

2022-01-28

Symptoms: Fever, myalgia less than a day after the vaccine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMyalgia · · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release